Response Biomedical Corp announced that it has been granted a Special 510(k) FDA clearance for an update to its RAMP Influenza A/B assay package insert to include analytical reactivity information for a strain of the 2009 H1N1 virus cultured from positive respiratory specimens.
Read MoreThe FDA has granted 510(k) clearance for an antibody cyclic-citrulinated peptide, or anti-CCP assay, to run on the world class systems.
Read MoreAEterna Zentaris Inc, announces that it has initiated activities intended to complete the clinical development of the growth hormone secretagogue (GHS) / ghrelin agonist compound macimorelin (AEZS-130) which could be the first oral diagnostic test approved for growth hormone deficiency (GHD).
Read MoreA team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy.
Read MoreQuotient Biodiagnostics Inc, announces that the FDA has approved its biologics license application (BLA) for the first 15 monoclonal antibodies in its proprietary line of transfusion diagnostics.
Read More